Skip to main content
TipRanks
Go Ultimate75% OFF

Bioxcel Therapeutics (BX20) Q2 2022 Earnings Report

10 Followers

DE:BX20 Q2 2022 EPS Results

Actual EPS
-EUR 19.69
Consensus EPS
-EUR 17.51
Beat/Miss
Missed by -EUR 2.18
One Year Ago EPS
-EUR 16.19

DE:BX20 Q2 2022 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2022
Date
08/09/2022
Time
Before Open
Conference Call
Tuesday, August 9, 2022
DE:BX20 Upcoming Earnings

Bioxcel Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:BX20 Earnings History

DE:BX20 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)―--0.53――
Nov 18, 20262026 (Q3)-0.92--1.99―
Aug 11, 20262026 (Q2)-0.40-0.44-2.2380.16% (+1.79)
May 15, 20262026 (Q1)-0.48-0.49-1.3764.00% (+0.88)
Mar 27, 20262025 (Q4)-0.58-0.53-3.2583.75% (+2.73)
Nov 12, 20252025 (Q3)-1.22-1.99-4.6757.42% (+2.68)
Aug 12, 20252025 (Q2)-1.69-2.23-3.0627.08% (+0.83)
May 12, 20252025 (Q1)-2.48-1.37-12.6989.22% (+11.32)
Mar 27, 20252024 (Q4)-5.51-3.25-11.0870.64% (+7.83)
Nov 14, 20242024 (Q3)-7.37-4.67-25.0981.40% (+20.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed